The altered expression of TP53 was more frequent in high grade tumor than low grade (66.7% vs. 28.6% respectively) and in T2 stage than Ta and T1 (66.7% vs. 28.6% respectively), giving rise to a statistically significant difference (p ≤ 0.05) (Table 2). The gene discussed is TP53; the disease is neoplasm.